Butterfly Network, Inc. (BFLY)
NYSE:BFLY
BFLY Stock Chart & Stats
$4.05
-$0.17(-4.21%)
At close: 4:00 PM EST
$4.05
-$0.17(-4.21%)
Day’s Range― - ―
52-Week Range$1.32 - $5.03
Previous CloseN/A
Volume2.30M
Average Volume (3M)4.58M
Market Cap
$1.05B
Enterprise Value$916.45M
Total Cash (Recent Filing)$150.49M
Total Debt (Recent Filing)$20.40M
Price to Earnings (P/E)―
Beta1.75
Next Earnings
Apr 30, 2026EPS Estimate
-0.04Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.02
Shares Outstanding228,205,930
10 Day Avg. Volume3,269,129
30 Day Avg. Volume4,575,012
Financial Highlights & Ratios
PEG Ratio1.38
Price to Book (P/B)4.79
Price to Sales (P/S)9.62
P/FCF Ratio-58.52
Enterprise Value/Market Cap0.88
Enterprise Value/Revenue9.39
Enterprise Value/Gross Profit20.04
Enterprise Value/Ebitda-13.60
Forecast
1Y Price Target
$5.75Price Target Upside41.98% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering4
EPS Forecast (FY)-0.14
Revenue Forecast (FY)$116.65M
Bulls Say, Bears Say
Bulls Say
Cash Flow And GuidanceAchieving positive operating cash flow alongside guidance characterized as conservative bolsters balance sheet stability and suggests potential upside versus Street expectations.
Revenue Mix And MarginsA shift toward software, services and licensing increases recurring revenue and improves gross margins by reducing reliance on amortization of past development costs.
Strategic Partnership And Market ExpansionThe Midjourney co‑development and licensing deal validates the company's semiconductor imaging intellectual property and creates a confidential non‑medical edge‑AI hardware opportunity that expands the addressable market beyond clinical ultrasound.
Bears Say
Execution And Market RisksSlow adoption of new medical practices, competitive pressure from larger players, intellectual property questions and continued cash burn could delay monetization of the company's expanded semiconductor and non‑medical opportunities.
Operating Costs PressureRising operating expenses driven by payroll tax adjustments, retirement plan resets and newly implemented tariffs can pressure profitability and constrain funds available for growth initiatives.
Revenue Quality And VisibilityReliance on partnership‑driven revenue not reflected in sell‑side models creates uncertainty about organic demand and the sustainability of reported growth.
Butterfly Network News
BFLY FAQ
What was Butterfly Network, Inc.’s price range in the past 12 months?
Butterfly Network, Inc. lowest stock price was $1.32 and its highest was $5.03 in the past 12 months.
What is Butterfly Network, Inc.’s market cap?
Butterfly Network, Inc.’s market cap is $1.05B.
When is Butterfly Network, Inc.’s upcoming earnings report date?
Butterfly Network, Inc.’s upcoming earnings report date is Apr 30, 2026 which is in 17 days.
How were Butterfly Network, Inc.’s earnings last quarter?
Butterfly Network, Inc. released its earnings results on Feb 26, 2026. The company reported -$0.02 earnings per share for the quarter, beating the consensus estimate of -$0.045 by $0.025.
Is Butterfly Network, Inc. overvalued?
According to Wall Street analysts Butterfly Network, Inc.’s price is currently Undervalued.
Does Butterfly Network, Inc. pay dividends?
Butterfly Network, Inc. does not currently pay dividends.
What is Butterfly Network, Inc.’s EPS estimate?
Butterfly Network, Inc.’s EPS estimate is -0.04.
How many shares outstanding does Butterfly Network, Inc. have?
Butterfly Network, Inc. has 228,205,930 shares outstanding.
What happened to Butterfly Network, Inc.’s price movement after its last earnings report?
Butterfly Network, Inc. reported an EPS of -$0.02 in its last earnings report, beating expectations of -$0.045. Following the earnings report the stock price went up 50.645%.
Which hedge fund is a major shareholder of Butterfly Network, Inc.?
Currently, no hedge funds are holding shares in BFLY
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Butterfly Network Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$5.75 (41.98% Upside)
$5.75 (41.98% Upside)
Blogger Sentiment
Bullish
BFLY Sentiment 70%
Sector Average ―
Sector Average ―
Hedge Fund Trend
Increased
By 4.5M Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $3.0M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Negative
Last 7 Days ▼ 0.9%
Last 30 Days ▼ 0.5%
Last 30 Days ▼ 0.5%
Technicals
SMA
Positive
20 days / 200 days
Momentum
79.47%
12-Months-Change
Fundamentals
Return on Equity
-35.34%
Trailing 12-Months
Asset Growth
15.80%
Trailing 12-Months
Company Description
Butterfly Network, Inc.
Butterfly Network, Inc., a digital health company, develops, manufactures, and commercializes ultrasound imaging solutions in the United States and internationally. It offers Butterfly iQ, a handheld and single-probe whole body ultrasound system; Butterfly iQ+, a point-of-care ultrasound imaging device that connects with a smartphone, tablet, and hospital computer system; and Butterfly Blueprint, a system-wide ultrasound platform with Compass software that integrates into a healthcare system's clinical and administrative infrastructure. The company also provides Butterfly system, which includes probes, and related accessories and software subscriptions, to healthcare systems, physicians, and healthcare providers through a direct sales force, distributors, and eCommerce channel. In addition, it offers cloud-based software solutions to healthcare systems, teleguidance, in-app educational tutorials, and formal education programs through its Butterfly Academy software, as well as clinical support and services. Butterfly Network, Inc. was incorporated in 2011 and is headquartered in Guilford, Connecticut.
BFLY Earnings Call
Q4 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call highlighted a strong turnaround in Q4 and FY2025 with record quarterly revenue (+41% YoY), significant margin and cash-flow improvements, a transformative Embedded partnership (Midjourney), an expanding software mix (+76% YoY for software & services) and clear R&D progress (P5.1 in production, Apollo in development). Challenges remain including international softness, a steep decline in iQ+ sales, continued adjusted EBITDA losses (albeit improved), and timing uncertainty for Embedded commercialization and home-care revenue. Overall the positive operational and financial momentum, solid cash position, and strategic partnerships materially outweigh the near-term and execution risks.View all BFLY earnings summariesBFLY Stock 12 Month Forecast
Average Price Target
$5.75
▲(41.98% Upside)
Technical Analysis
Varex Imaging
―
OrthoPediatrics
―
Bioventus
―
Treace Medical Concepts
―
Ceribell, Inc.
―
Ownership Overview
30.37% Insiders
7.88% Mutual Funds
22.43% Other Institutional Investors
26.91% Public Companies and
Individual Investors